APRIL HANEY: Open Payments
NPI 1508844580 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 28 payments from 12 companies in 2025. Trend: 2023 $412 · 2024 $504 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $129 |
| Novo Nordisk Inc | 4 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| OPKO Pharmaceuticals, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: IBSRELA, Ozempic, Kerendia, Fabhalta, REXULTI, RAYALDEE, FARXIGA, OTEZLA.
Industry payments across AL — which companies pay providers there.
